Profile picture

Professor Christoph J Binder

Medical University of Vienna, Vienna (Austria)
Follow
Biography
Christoph J. Binder received his MD from the University of Vienna, Austria, in 1997 and his PhD in Molecular Pathology from the University of California San Diego, USA, in 2002. Following postdoctoral training at the Dept. of Medicine at UCSD, he established his own research group at the Department of Laboratory Medicine at the Medical University of Vienna in 2005. In 2006 he joined the Center for Molecular Medicine of the Austrian Academy of Sciences as Principal Investigator and in 2009 was appointed Professor of Atherosclerosis Research at the Medical University of Vienna. Christoph Binder is investigating immune mechanisms of atherosclerosis with a special focus on the role of innate and humoral immunity and how this can be exploited for the treatment of CVD. He is Co-Editor of the Journal Atherosclerosis and Section Editor of Thrombosis & Haemostasis.
Logo ESC

Contributor content

Great Debate: anti-inflammatory therapy should be a part of atherosclerotic cardiac disease treatment
Session
Great Debate: anti-inflammatory therapy should be a part of atherosclerotic cardiac disease treatment
1 September 2025
Impact of the environment (exposome) on cardiovascular health
Session
Impact of the environment (exposome) on cardiovascular health
1 September 2025
Late-Breaking Clinical Trials: vaccinations in cardiovascular prevention
Session
Late-Breaking Clinical Trials: vaccinations in cardiovascular prevention
30 August 2025
Lipids and adipose tissue interaction in cardiovascular disease
Session
Lipids and adipose tissue interaction in cardiovascular disease
30 August 2024
Bed to bench and back: anti-vulnerable plaque strategies
Session
Bed to bench and back: anti-vulnerable plaque strategies
13 April 2024
Tuning the heat: inflammatory risk in atherosclerosis
Session
Tuning the heat: inflammatory risk in atherosclerosis
12 April 2024
Novel insights in signaling pathways in endothelial dysfunction
Session
Novel insights in signaling pathways in endothelial dysfunction
20 April 2018

ESC 365 is supported by